Print Page | Contact Us | Sign In | Join ACAM
eMedTalks Series: Chelation Therapy Data Review & Development: An Inside Look
Tell a Friend About This EventTell a Friend
 

​​​​​About the Webinar: The National Institutes of Health authorized a $37 million grant for Dr. Gervasio Lamas to conduct a follow-up study to determine whether chelation is as beneficial as conventional therapies — or more so — in preventing heart attacks in diabetics.

6/30/2020
When: June 30th, 2020
5:00 PM (PT)
Where: Online Webinar
United States

« Go to Upcoming Event List  

eMedTalks Series: Chelation Therapy Data Review & Development: An Inside Look

Join Speaker Dorothy Merritt, MD 
About the Webinar:


The National Institutes of Health authorized a $37 million grant for Dr. Gervasio Lamas to conduct a follow-up study to determine whether chelation is as beneficial as conventional therapies — or more so — in preventing heart attacks in diabetics.

The five-year study started in 2016— the Trial to Assess Chelation Therapy (TACT2) —involves researchers at more than 100 other leading medical institutions in the U.S. and Canada.

This webinar will cover TACT 2 and TACT 3, as well as the data that is currently showing that people with vascular disease have a total body burden of excessive metals.   We will discuss Calcium vs Sodium EDTA differences with respect to metals.   Find out the different delivery options currently being used, including suppository forms.


To register click here

Connect With Us

380 Ice Center Lane, Suite C

Bozeman, MT 59718

Our mission

The American College for Advancement in Medicine (ACAM) is a not-for-profit organization dedicated to educating physicians and other health care professionals on the safe and effective application of integrative medicine.